Suppliers / Lincoln Pharmaceuticals

Lincoln Pharmaceuticals

India 902 employees 3 duplicate records merged Updated 9 July 2026

Lincoln Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 371 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ), ZAMRA (ZM) and EFDA (ET). Its GMP standing is certified by CDSCO (India), NAFDAC (NG) and TMDA (TZ), among 4 authorities. Customs aggregates show $46.4M of exports covering 3,321 molecules to 45 destinations in 2025.

0
active US DMFs
0
valid CEPs
6
registered plants 1 with an FDA FEI number
371
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Gandhinagar, India 3007623760
vadodara, India Not on file
mehsana 382 732, India Not on file
lakhabavad 361 006jamnagar, India Not on file
ta kalolgandhinagar 382 729, India Not on file
Gujarat State, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
TMDA (TZ) 195 1
ZAMRA (ZM) 55 None
EFDA (ET) 55 None
MCAZ (ZW) 47 None
NAFDAC (NG) 19 2
CDSCO (India) None 6
FDA (GH) None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $7.1M 33
2025 Not reported $46.4M 45
2024 Not reported $46.4M 42
2023 Not reported $38.4M 36

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Lincoln Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts